Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.

Source:http://linkedlifedata.com/resource/pubmed/id/17878341

J. Immunol. 2007 Oct 1 179 7 4451-63

Download in:

View as

General Info

PMID
17878341